Anzeige
Erschienen in:
01.08.2006 | Commentary
Etomidate, pharmacological adrenalectomy and the critically ill: a matter of vital importance
Erschienen in: Critical Care | Ausgabe 4/2006
Einloggen, um Zugang zu erhaltenAbstract
Etomidate is a potent suppressant of adrenal steroidogenesis, effectively inducing reversible pharmacological adrenalectomy. Recent evidence suggests that for every five patients with septic shock given etomidate without corticosteroid supplementation, one patient will die as a consequence. Other critically ill patients are also at possible risk, and this risk requires further exploration. Etomidate will also confound investigations into the effects of disease states on adrenal function, and should therefore be avoided. A moratorium on the use of etomidate in critically ill patients outside clinical trials may be prudent until its safety is established.